Related references
Note: Only part of the references are listed.Synthesis and Structure-Activity Relationship Studies of Urea-Containing Pyrazoles as Dual Inhibitors of Cyclooxygenase-2 and Soluble Epoxide Hydrolase
Sung Hee Hwang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Structure-Based Discovery of Natural-Product-like TNF-alpha Inhibitors
Daniel Shiu-Hin Chan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase
Anne B. Eldrup et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Incorporation of Piperazino Functionality into 1,3-Disubstituted Urea as the Tertiary Pharmacophore Affording Potent Inhibitors of Soluble Epoxide Hydrolase with Improved Pharmacokinetic Properties
Shao-Xu Huang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
1-Aryl-3-(1-acylpiperidin-4-yl)urea Inhibitors of Human and Murine Soluble Epoxide Hydrolase: Structure-Activity Relationships, Pharmacokinetics, and Reduction of Inflammatory Pain
Tristan E. Rose et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors
Hong C. Shen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Discovery of a Highly Potent, Selective, and Bioavailable Soluble Epoxide Hydrolase Inhibitor with Excellent Ex Vivo Target Engagement
Hong C. Shen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Microsomal prostaglandin E2 synthase-1 (mPGES-1):: A novel anti-inflammatory therapeutic target
Richard W. Friesen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Reaching for high-hanging fruit in drug discovery at protein-protein interfaces
James A. Wells et al.
NATURE (2007)
Orally bioavailable potent soluble epoxide hydrolase inhibitors
Sung Hee Hwang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors
Sung Hee Hwang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Lp-PLA(2): A new kid on the block
Andrew Zalewski et al.
CLINICAL CHEMISTRY (2006)
Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility
IH Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
11,12-Epoxyeicosatrienoic acid (11,12-EET):: Structural determinants for inhibition of TNF-α-induced VCAM-1 expression
JR Falck et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Design and synthesis of orally active benzamide derivatives as potent serotonin 4 receptor agonist
S Sonda et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
Potential cardioprotective actions of no-releasing aspirin
JL Wallace et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Hepoxilin B-3 and its enzymatically formed derivative trioxilin B-3 are incorporated into phospholipids in psoriatic lesions
R Anton et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Activation of Gαs mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids
K Node et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells - Implications for the vascular effects of soluble epoxide hydrolase inhibition
X Fang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Inhibition of microsomal epoxide hydrolases by ureas, amides, and amines
C Morisseau et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
Epoxide hydrolases: biochemistry and molecular biology
AJ Fretland et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2000)
Suppression of CYP2C11 gene transcription by interleukin-1 mediated by NF-κB binding at the transcription start site
H Iber et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
Share Paper
